Dr. Colin Dayan

Professor of Clinical Diabetes and Metabolism, Cardiff University School of Medicine. Dr. Colin Dayan trained in medicine at University College, Oxford, and Guy’s and Charing Cross Hospitals in London, UK before obtaining a PhD in the cellular immunology of Graves’ Disease in Laboratory of Marc Feldmann. He then spent a year as an endocrine fellow at the Massachussetts General Hospital in Boston, USA before completing his specialist training in diabetes and endocrinology as a Lecturer in Bristol. Dr. Dayan became a consultant senior lecturer in medicine (diabetes/endocrinology) at the University of Bristol in 1995 and Head of Clinical Research at the Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology in Bristol in 2002. He served as Director of the Institute of Molecular and Experimental Medicine in 2011 – 2015 and was appointed at Cardiff Joint Research Office Director in 2021. Dr. Dayan is also a Senior Research Fellow at the Univesity of Oxford and a Fellow of the Association of Physicians of Great Britain and Ireland.
He has a long established interest in translational research in the immunopathology of type 1 diabetes (T1D). He supported the application to the FDA for the first licensed Immunotherapy for T1D in 2022. He was awarded the Sir Derrick Melville Dunlop Medal from the Royal College of Physicians of Edinburgh and the JDRF International/Breakthrough T1D David Rumbough prize.
He also has research interests in thyroid disease which include thyroid autoimmunity, thyroid hormone replacement and bioavailability, genetic epidemiology as applied to population variation in thyroid hormone bioavailability and thyroid eye disease